Seeking Alpha

Israeli biotech Rosetta Genomics (ROSG -4%) dips after agreeing to sell its 50% stake in Rosetta...

Israeli biotech Rosetta Genomics (ROSG -4%) dips after agreeing to sell its 50% stake in Rosetta Green, as the firm seeks to improve its cash position and expand the commercialization of its products.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|